Skip to content

Drug interactions

Roflumilast + Tucatinib

Severity: Moderate

Roflumilast and Tucatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib inhibits CYP3A4 and may increase roflumilast exposure, increasing the likelihood of gastrointestinal, weight and psychiatric adverse effects.

What this interaction means in plain words

Roflumilast and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Roflumilast belongs to Respiratory; Tucatinib belongs to Oncology.

Evidence level: Low

Why it happens

Tucatinib inhibits CYP3A4, decreasing roflumilast clearance.

What to do

Monitor for roflumilast adverse effects and weight loss, and consider holding roflumilast if intolerance develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Roflumilast and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Roflumilast with Tucatinib?

MediHelp rates the interaction as moderate. Roflumilast and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tucatinib inhibits CYP3A4 and may increase roflumilast exposure, increasing the likelihood of gastrointestinal, weight and psychiatric adverse effects.

How serious is the interaction between Roflumilast and Tucatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for roflumilast adverse effects and weight loss, and consider holding roflumilast if intolerance develops.

What other medicines interact with Roflumilast?

MediHelp also lists interactions of Roflumilast with, for example, Apalutamide, Carbamazepine, Efavirenz. The full list is on the Roflumilast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in